Numinus Advances Phase 1 Trial on Proprietary Psilocybin Product
Finalized study design and protocol mark major milestone to investigate natural Psilocybin Numinus Wellness Inc. a leader in psychedelics-focused mental healthcare, is pleased to have finalized the study design and protocol for a Phase 1 clinical trial on a naturally derived Psilocybin extract, previously announced on April 26, 2021 . This major milestone advances Numinus' investigation of its first proprietary ...
Source: investingnews.com
